Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

27.27

+0.53 (1.98%)

At close: Aug 11, 2026, 4:00 PM EDT

27.27

0.00 (0.00%)

After-hours: Aug 11, 2026, 4:20 PM EDT

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.12	58.45	38.34	19.84	52.42	45.63
Short-Term Investments	195.48	189.66	73.74	110.41	39.19	101
Cash & Short-Term Investments	226.6	248.11	112.08	130.25	91.61	146.63
Cash Growth	148.94%	121.37%	-13.95%	42.18%	-37.52%	-32.25%
Accounts Receivable	0.45	0.97	-	0.04	0.94	0.34
Other Current Assets	5.56	5.47	3.42	3.5	4.41	7.24
Total Current Assets	232.61	254.55	115.5	133.79	96.97	154.2
Net Property, Plant & Equipment	2.58	2.73	3.35	2.72	3.94	7.18
Long-Term Investments	-	-	-	-	-	27.97
Other Long-Term Assets	0.31	0.31	0.31	0.31	0.89	1.7
Total Assets	235.51	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.13	1.17	0.59	0.46	2.49	2.66
Accrued Expenses	4.2	10.14	9.14	6.63	10.44	10.26
Current Portion of Leases	0.59	0.57	0.46	1.22	3.36	3.15
Unearned Revenue	29.08	36.9	37.62	30.92	-	-
Total Current Liabilities	35	48.78	47.8	39.23	16.3	16.07
Long-Term Leases	1.9	2.06	2.63	1.12	0.1	3.33
Other Long-Term Liabilities	-	-	35.38	55.38	2.73	2.73
Total Long-Term Liabilities	1.9	2.06	38.01	56.5	2.83	6.06
Total Liabilities	36.9	50.84	85.81	95.73	19.13	22.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0	0.05
Additional Paid-in Capital	1,040	1,039	859.49	826.92	807.98	800.73
Accumulated Other Comprehensive Income	-0.37	-0.04	-0.21	-0.08	-0.8	-0.42
Retained Earnings	-841.13	-832.05	-825.93	-785.75	-724.52	-631.43
Shareholders' Equity	198.61	206.75	33.36	41.1	82.66	168.93
Total Liabilities & Equity	235.51	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.49	2.63	3.09	2.34	3.47	6.48
Net Cash (Debt)	224.11	245.48	108.99	127.91	88.15	140.15
Net Cash Growth	154.65%	125.23%	-14.79%	45.11%	-37.11%	-32.06%
Net Cash Per Share	16.55	21.90	18.15	27.94	21.85	38.86
Book Value	198.61	206.75	33.36	41.1	82.66	168.93
Book Value Per Share	14.66	18.44	5.56	8.98	20.49	46.84
Tangible Book Value	198.61	206.75	33.36	41.1	82.66	168.93
Tangible Book Value Per Share	14.66	18.44	5.56	8.98	20.49	46.84

SEC Filings: 10-K · 10-Q